Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 13/20 | 0.54 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1664561 | 0.94 | HPGDS (0.51) | HPGDSRAB9ACSF1R | |
| SCHEMBL1664362 | 0.88 | HPGDS (0.56) | HPGDSPDE7ARAB9AEGFR | |
| SCHEMBL1664452 | 0.87 | HPGDS (0.48) | HPGDS | |
| SCHEMBL1664868 | 0.87 | HPGDS (0.57) | HPGDSPDE7ARAB9AEGFRGAA | |
| SCHEMBL1663363 | 0.86 | HPGDS (0.56) | HPGDSPDE7ARAB9AEGFR | |
| SCHEMBL1664802 | 0.85 | HPGDS (0.55) | HPGDSPDE7ARAB9AEGFR | |
| SCHEMBL1666155 | 0.84 | HPGDS (0.56) | HPGDSPDE7AEGFRCSF1R | |
| SCHEMBL1664686 | 0.84 | HPGDS (0.54) | HPGDSPDE7AEGFR | |
| SCHEMBL1664676 | 0.84 | HPGDS (0.54) | HPGDSPDE7ARAB9AEGFRMAPK10 | |
| SCHEMBL1664928 | 0.84 | HPGDS (0.55) | HPGDSRAB9AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2642994-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | Ligand Pharmaceuticals Incorporated (US) | 2013-10-02 | — | — | EP | disclosed |
| EP-2488486-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | Ligand Pharmaceuticals Inc. (US) | 2012-08-22 | — | — | EP | disclosed |
| WO-2012068406-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2011046954-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2011-04-21 | — | — | WO | disclosed |